Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPHERIC-1 sildenafil versus placebo in COPD-associated pulmonary hypertension
2010-020917-97Phase 3Completed
- Sponsor
- Associazione Italiana Pneumologi Ospedalieri
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD-PH) and chronic obstructive pulmonary disease (COPD) comparing Sildenafil with Placebo (2 arms). Started Dec 2011; status: completed.
02
Drugs
sildenafil
03
Conditions
Pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD-PH)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-020917-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020917-97.